Our present results demonstrated that high Ki-67 expression is an independent factor associated with a histologic upgrade from DCIS and suggest the potential use of this parameter for predicting an invasive component in patients with biopsy-proven DCIS. The gene discussed is MKI67; the disease is ductal breast carcinoma in situ.